Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hester Biosciences Ltd Audit Report / Information 2024

Oct 10, 2024

62222_rns_2024-10-10_22b193d7-a92d-4309-b228-41ea5e1d890c.pdf

Audit Report / Information

Open in viewer

Opens in your device viewer

==> picture [596 x 111] intentionally omitted <==

10 October 2024

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524669

To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051

Symbol: HESTERBIO

Dear Sir/ Madam:

Subject: Intimation regarding receipt of GST Audit Report from GST Department, Ahmedabad for period from April 2018 to March 2023

Pursuant to the provisions of Regulation 30 read with sub-para 20 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (“Listing Regulations”), we hereby submit that the Company is in receipt of an Order passed by Additional Commissioner of Circle-X, CGST, Audit - Ahmedabad, from the Office of the Commissioner of Central Tax Audit Ahmedabad.

The details of the above are given below:

The details of the above are given below:
Name of the authority(s) Additional Commissioner, Office of the Commissionerof Central Tax Audit, Ahmedabad
Nature and details of the action(s)taken, initiated or order(s) passed GST Audit Report under section 65(6) of CGST Act,2017, for the period April 2018 to March 2023 hasmade audit objection for excess input tax creditamounting ₹1.3 million and levied interest of ₹0.4million and penalty of ₹0.2 million
Date of receipt of direction or order,including any ad-interim or interimorders, or any other communicationfrom the authority 9 October 2024
Detailsoftheviolation(s)/contravention(s) committed or allegedto be committed; Excess ITC of aforesaid amount over the period of 5years is objected on account of difference betweenbalance in GSTR 3B vs GSTR 2A and ITC on certainexpenses claimed
Impact on financial, operation or otheractivities of the listed entity, quantifiablein monetary terms to the extent possible The Company does not expect any material impact ofthe stated demand on financial, operations or otheractivities of the Company. The Company shall filenecessary submissions to the Authorities.

You are requested to take the above information on your record.

Sincerely For Hester Biosciences Limited

Digitally signed Vinod by Vinod Mali Date: 2024.10.10 Mali 17:19:08 +05'30'

Vinod Mali Company Secretary & Compliance Officer